The Effects of Homologous Cross‐Circulation and In Situ Liver Perfusion on Fulrninant Hepatic Failure Rats
Authors:
- 1 August 1980
- journal article
- research article
- Published by Wiley in Artificial Organs
- Vol. 4 (3) , 171-175
Abstract
A galactosamine-induced fulminant hepatic failure (FHF) rat model was used to study the effects of homologous cross-circulation and in situ liver perfusion. Cross-circulation with homologous donors did not significantly improve the survival time or recovery rate of grade II hepatic coma rats. Homologous in situ liver perfusion significantly improved the survival time and recovery in FHF only when started in grade II coma; it has no effect in the latter stage of coma.Keywords
This publication has 19 references indexed in Scilit:
- Biochemical, Hematological and Histological Changes in a Fulminant HeDatic Failure Rat Model for Ahificial Liver AssessmentArtificial Organs, 1979
- Artificial Liver: The Effect of ACAC Microencapsulated Charcoal Hemoperfusion on Fulminant Hepatic FailureArtificial Organs, 1977
- Acute hepatic failure treated by cross circulationArchives of internal medicine (1960), 1973
- CHARACTERIZATION OF POSSIBLE “TOXIC” METABOLITES IN UREMIA AND HEPATIC COMA BASED ON THE CLEARANCE SPECTRUM FOR LARGER MOLECULES BY THE ACAC MICROCAPSULE ARTIFICIAL KIDNEYASAIO Journal, 1973
- EXTRACORPOREAL PIG-LIVER PERFUSION IN TREATMENT OF HEPATIC COMA DUE TO FULMINANT HEPATITISThe Lancet, 1971
- LONG-TERM HEPATIC SUPPORT BY INTERMITTENT MULTI-SPECIES LIVER PERFUSIONSThe Lancet, 1970
- TREATMENT OF HEPATIC COMA BY EXTRACORPOREAL PIG-LIVER PERFUSIONThe Lancet, 1969
- Heterologous liver perfusion in acute hepatic failure.BMJ, 1967
- Heterologous Liver Perfusion in Treatment of Hepatic FailureAnnals of Surgery, 1965
- Observations on cross circulation in manThe American Journal of Medicine, 1965